0001759778-18-000001.txt : 20181127
0001759778-18-000001.hdr.sgml : 20181127
20181127151247
ACCESSION NUMBER: 0001759778-18-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20181127
DATE AS OF CHANGE: 20181127
EFFECTIVENESS DATE: 20181127
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pattern Pharma Inc.
CENTRAL INDEX KEY: 0001759778
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-326610
FILM NUMBER: 181202970
BUSINESS ADDRESS:
STREET 1: 31 RIDGE DR.
CITY: TORONTO
STATE: A6
ZIP: M4T 1B6
BUSINESS PHONE: 416-302-5155
MAIL ADDRESS:
STREET 1: 31 RIDGE DR.
CITY: TORONTO
STATE: A6
ZIP: M4T 1B6
D
1
primary_doc.xml
X0708
D
LIVE
0001759778
Pattern Pharma Inc.
31 RIDGE DR.
TORONTO
A6
ONTARIO, CANADA
M4T 1B6
416-302-5155
ONTARIO, CANADA
None
None
Corporation
true
2018
Mark
Frans
van Coeverden de Groot
31 Ridge Dr.
Toronto
A6
ONTARIO, CANADA
M4T 1B6
Executive Officer
Director
Pharmaceuticals
No Revenues
- 06b
false
2018-11-12
true
true
true
true
true
The Special Equity Rights are convertible into shares of the issuer on the 12th of November 2020, or prior to said date on the occurrence of certain events.
true
0
40000
40000
0
false
2
0
0
0
In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors.
false
Pattern Pharma Inc.
Mark Frans van Coeverden de Gr
Mark Frans van Coeverden de Groot
President & Chief Executive Officer
2018-11-26